| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | Plasmodium falciparum (isolate 3D7) Transmission-blocking |
| | target antigen S230 (a.a.61-460) |
| | Swiss-Prot #: | P68874 |
| | Entry name: | S230_PLAF7 |
| | Protein | Transmission-blocking target antigen S230 |
| | Gene names: | S230 (PFB0405W) |
| | Organism: | Plasmodium falciparum (isolate 3D7) |
| | Codon-optimized cDNA Clone |
| | Cat#: | RPL-0458 |
| | Description: | Applications:1. Codon-optimized cDNA sequence designed for recombinant |
| | protein production in both E.coli and Mammalian cell. The cDNA has been |
| | cloned into E.coli expression vector with 6x Histidine tag. 2. May be used as |
| | RNAi assistance to restore the loss-of-function. |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Recombinant Protein |
| | Cat#: | PL-0458 |
| | Source: | Recombinant protein derived from E.coli. Or Yeast |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Purity: | > 90%, as determined by SDS-PAGE under reducing conditions |
| | Activity: | N/A |
| | Applications: | Western Blot, may be used for other applications determined by |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Sequence: | | MKKIITLKNL FLIILVYIFS EKKDLRCNVI KGNNIKDDED KRFHLFYYSH NLFKTPETKE KKNKKECFYK NGGIYNLSKE |
| | IRMRKDTSVK IKQRTCPFHK EGSSFEMGSK NITCFYPIVG KKERKTLDTI IIKKNVTNDH VVSSDMHSNV QEKNMILIRN |
| | IDKENKNDIQ NVEEKIQRDT YENKDYESDD TLIEWFDDNT NEENFLLTFL KRCLMKIFSS PKRKKTVVQK KHKSNFFINS |
| | SLKYIYMYLT PSDSFNLVRR NRNLDEEDMS PRDNFVIDDE EEEEEEEEEE EEEEEEEEEE EEEEYDDYVY EESGDETEEQ |
| | LQEEHQEEVG AESSEESFND EDEDSVEARD GDMIRVDEYY EDQDGDTYDS TIKNEDVDEE VGEEVGEEVG EEVGEEVGEE |
| | VGEEVGEEVG EEVGEEEGEE VGEGVGEEVG EEEGEEVGEE EGEYVDEKER QGEIYPFGDE EEKDEGGESF TYEKSEVDKT |
| | DLFKFIEGGE GDDVYKVDGS KVLLDDDTIS RVSKKHTARD GEYGEYGEAV EDGENVIKII RSVLQSGALP SVGVDELDKI |
| | DLSYETTESG DTAVSEDSYD KYASNNTNKE YVCDFTDQLK PTESGPKVKK CEVKVNEPLI KVKIICPLKG SVEKLYDNIE |
| | YVPKKSPYVV LTKEETKLKE KLLSKLIYGL LISPTVNEKE NNFKEGVIEF TLPPVVHKAT VFYFICDNSK TEDDNKKGNR |
| | GIVEVYVEPY GNKINGCAFL DEDEEEEKYG NQIEEDEHNE KIKMKTFFTQ NIYKKNNIYP CYMKLYSGDI GGILFPKNIK |
| | STTCFEEMIP YNKEIKWNKE NKSLGNLVNN SVVYNKEMNA KYFNVQYVHI PTSYKDTLNL FCSIILKEEE SNLISTSYLV |
| | YVSINEELNF SLFDFYESFV PIKKTIQVAQ KNVNNKEHDY TCDFTDKLDK TVPSTANGKK LFICRKHLKE FDTFTLKCNV |
| | NKTQYPNIEI FPKTLKDKKE VLKLDLDIQY QMFSKFFKFN TQNAKYLNLY PYYLIFPFNH IGKKELKNNP TYKNHKDVKY |
| | FEQSSVLSPL SSADSLGKLL NFLDTQETVC LTEKIRYLNL SINELGSDNN TFSVTFQVPP YIDIKEPFYF MFGCNNNKGE |
| | GNIGIVELLI SKQEEKIKGC NFHESKLDYF NENISSDTHE CTLHAYENDI IGFNCLETTH PNEVEVEVED AEIYLQPENC |
| | FNNVYKGLNS VDITTILKNA QTYNINNKKT PTFLKIPPYN LLEDVEISCQ CTIKQVVKKI KVIITKNDTV LLKREVQSES |
| | TLDDKIYKCE HENFINPRVN KTFDENVEYT CNIKIENFFN YIQIFCPAKD LGIYKNIQMY YDIVKPTRVP QFKKFNNEEL |
| | HKLIPNSEML HKTKEMLILY NEEKVDLLHF YVFLPIYIKD IYEFNIVCDN SKTMWKNQLG GKVIYHITVS KREQKVKGCS |
| | FDNEHAHMFS YNKTNVKNCI IDAKPKDLIG FVCPSGTLKL TNCFKDAIVH TNLTNINGIL YLKNNLANFT YKHQFNYMEI |
| | PALMDNDISF KCICVDLKKK KYNVKSPLGP KVLRALYKKL NIKFDNYVTG TDQNKYLMTY MDLHLSHKRN YLKELFHDLG |
| | KKKPADTDAN PESIIESLSI NESNESGPFP TGDVDAEHLI LEGYDTWESL YDEQLEEVIY NDIESLELKD IEQYVLQVNL |
| | KAPKLMMSAQ IHNNRHVCDF SKNNLIVPES LKKKEELGGN PVNIHCYALL KPLDTLYVKC PTSKDNYEAA KVNISENDNE |
| | YELQVISLIE KRFHNFETLE SKKPGNGDVV VHNGVVDTGP VLDNSTFEKY FKNIKIKPDK FFEKVINEYD DTEEEKDLES |
| | ILPGAIVSPM KVLKKKDPFT SYAAFVVPPI VPKDLHFKVE CNNTEYKDEN QYISGYNGII HIDISNSNRK INGCDFSTNN |
| | SSILTSSVKL VNGETKNCEI NINNNEVFGI ICDNETNLDP EKCFHEIYSK DNKTVKKFRE VIPNIDIFSL HNSNKKKVAY |
| | AKVPLDYINK LLFSCSCKTS HTNTIGTMKV TLNKDEKEEE DFKTAQGIKH NNVHLCNFFD NPELTFDNNK IVLCKIDAEL |
| | FSEVIIQLPI FGTKNVEEGV QNEEYKKFSL KPSLVFDDNN NDIKVIGKEK NEVSISLALK GVYGNRIFTF DKNGKKGEGI |
| | SFFIPPIKQD TDLKFIINET IDNSNIKQRG LIYIFVRKNV SENSFKLCDF TTGSTSLMEL NSQVKEKKCT VKIKKGDIFG |
| | LKCPKGFAIF PQACFSNVLL EYYKSDYEDS EHINYYIHKD KKYNLKPKDV IELMDENFRE LQNIQQYTGI SNITDVLHFK |
| | NFNLGNLPLN FKNHYSTAYA KVPDTFNSII NFSCNCYNPE KHVYGTMQVE SDNRNFDNIK KNENVIKNFL LPNIEKYALL |
| | LDDEERQKKI KQQQEEEQQE QILKDQDDRL SRHDDYNKNH TYILYDSNEH ICDYEKNESL ISTLPNDTKK IQKSICKINA |
| | KALDVVTIKC PHTKNFTPKD YFPNSSLITN DKKIVITFDK KNFVTYIDPT KKTFSLKDIY IQSFYGVSLD HLNQIKKIHE |
| | EWDDVHLFYP PHNVLHNVVL NNHIVNLSSA LEGVLFMKSK VTGDETATKK NTTLPTDGVS SILIPPYVKE DITFHLFCGK |
| | STTKKPNKKN TSLALIHIHI SSNRNIIHGC DFLYLENQTN DAISNNNNNS YSIFTHNKNT ENNLICDISL IPKTVIGIKC |
| | PNKKLNPQTC FDEVYYVKQE DVPSKTITAD KYNTFSKDKI GNILKNAISI NNPDEKDNTY TYLILPEKFE EELIDTKKVL |
| | For pricing and availability Click Here >>> |
| | Protein-cDNA-Transmission-blocking-target-antigen-S230-Plasmodium |
| | FOR in vitro RESEARCH USE ONLY. NOT FOR USE IN HUMANS. |
|
| ||||||||||||||||||||||||||||||||||
| |||||
| For cDNA or Recombinant Protein Search (Input Cat#, Gene name, Protein Name, Accession Number |
|
Copyright Bioclone Inc All rights Reserved